Baoping Lu
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Biliary disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database.
Journal: Journal of chemotherapy (Florence, Italy)
Published: January 13, 2026
Targeting the intestinal barrier with traditional Chinese medicine for non-alcoholic fatty liver disease: mechanistic insights and therapeutic perspectives.
Journal: Chinese medicine
Published: October 14, 2025
Exploring the Top 50 Drugs Associated with Restless Legs Syndrome Based on the FDA Data from 2004 to 2024.
Journal: Nature and science of sleep
Published: December 24, 2024
Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway.
Journal: International immunopharmacology
Published: July 31, 2024
Depression and NAFLD risk: A meta-analysis and Mendelian randomization study.
Journal: Journal of affective disorders
Published: December 15, 2023
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis.
Journal: Annals of hepatology
Published: September 19, 2023
Formononetin protects against concanavalin-A-induced autoimmune hepatitis in mice through its anti-apoptotic and anti-inflammatory properties.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: March 22, 2021
α‑lipoic acid protects against carbon tetrachloride‑induced liver cirrhosis through the suppression of the TGF‑β/Smad3 pathway and autophagy.
Journal: Molecular medicine reports
Published: April 25, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026